Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia
This summary needs review. Please check the official study record and contact the research team for details.
In Hod HaSharon
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This summary needs review. Please check the official study record and contact the research team for details.
In Hod HaSharonThis summary needs review. Please check the official study record and contact the research team for details.
In LondonThis summary needs review. Please check the official study record and contact the research team for details.
In BristolThis summary needs review. Please check the official study record and contact the research team for details.
In FredrikstadThis study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
In ConcordThis study exists to compare options and see whether ketamine treatment offers something meaningfully different. Researchers are trying to understand what ketamine treatment could change in day-to-day care and decision-making.
Multiple locations, including AmiensThis summary needs review. Please check the official study record and contact the research team for details.
In LilleThis study was terminated in Lithuania. It is testing cariprazine for schizophrenia.
In LithuaniaThis summary needs review. Please check the official study record and contact the research team for details.
In MontpellierThis study is looking at whether a digital support tool can help people with depression or anxiety. Participants take part in the program and complete follow-up questionnaires or assessments.
Multiple locations, including NiceThis summary needs review. Please check the official study record and contact the research team for details.
In São PauloThis study is completed in Germany. It focuses on Schizophrenia.
In GermanyHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.